| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.953 | 10.082 | 11.215 | 3.018 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 20.953 | 10.082 | 11.215 | 3.018 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 20.141 | 10.454 | 11.266 | 3.036 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 812 | -372 | -51 | -18 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 184 | -674 | -387 | -109 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vita Med Line Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 92 | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 15.598 | 1.069 | 435 | 427 | 419 | 411 | 402 | 403 | 402 | 400 |
| Inventories | 10.853 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.584 | 1.100 | 435 | 427 | 419 | 411 | 402 | 403 | 402 | 400 |
| Cash | 2.161 | -31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -1.159 | -1.821 | -2.178 | -2.246 | -2.203 | -2.161 | -2.113 | -2.120 | -2.113 | -2.102 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 16.848 | 2.931 | 2.613 | 2.674 | 2.622 | 2.572 | 2.515 | 2.523 | 2.515 | 2.501 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Vita Med Line Srl